Not applicableStudy completedNCT02487472What this trial is testingBurden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in FranceWho this might be right forHerpes Zoster GlaxoSmithKline 106
Not applicableNot Yet RecruitingNCT06364033What this trial is testingBiological and Clinical Efficacy of Shingrix in Patients With CLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL-like MBL+1 more Gruppo Italiano Malattie EMatologiche dell'Adulto 312
Post-approval studies (Phase 4)Study completedNCT04169009What this trial is testingPersistence of Protection by ShingrixWho this might be right forHerpes Zoster University of Colorado, Denver 105
Large-scale testing (Phase 3)Study completedNCT02690207What this trial is testingCross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.Who this might be right forHerpes Zoster GlaxoSmithKline 8,687
Not applicableLooking for participantsNCT07361809What this trial is testingThe Analgesic Efficacy and Safety of Desvenlafaxine in Patients With Herpes ZosterWho this might be right forHerpes ZosterPain Beijing Tiantan Hospital 750
Early research (Phase 1)Ended earlyNCT00005009What this trial is testingEvaluation of the Safety of Varivax® in Pediatric Renal Transplant RecipientsWho this might be right forKidney Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 7
Not applicableStudy completedNCT00006131What this trial is testingRandomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes ZosterWho this might be right forHerpes ZosterImmunologic Deficiency Syndromes National Center for Research Resources (NCRR) 66
Not applicableStudy completedNCT03903237What this trial is testingHerpes Zoster: Risk Factors, Complications and Special SituationsWho this might be right forHerpes Zoster University Hospital, Basel, Switzerland 355
Testing effectiveness (Phase 2)Study completedNCT02526745What this trial is testingSafety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and OlderWho this might be right forHerpes Zoster Beijing Chaoyang District Centre for Disease Control and Prevention 440
Large-scale testing (Phase 3)Study completedNCT04176939What this trial is testingTest GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune ResponseWho this might be right forHerpes Zoster GlaxoSmithKline 68
Testing effectiveness (Phase 2)Study completedNCT04072497What this trial is testingA Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 YearsWho this might be right forHerpes Zoster Shanghai Institute Of Biological Products 522
Large-scale testing (Phase 3)Study completedNCT05219253What this trial is testingA Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in IndiaWho this might be right forHerpes Zoster GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT01229267What this trial is testingEvaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)Who this might be right forHerpes Zoster Merck Sharp & Dohme LLC 1,257
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06801509What this trial is testingEvaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster VaccineWho this might be right forHerpes Zoster Sinocelltech Ltd. 540
Not applicableUnknownNCT05952271What this trial is testingHerpes Zoster Hospitalizations in ItalyWho this might be right forHerpes ZosterComorbidities and Coexisting Conditions University of L'Aquila 72,000
Testing effectiveness (Phase 2)Study completedNCT00802464What this trial is testingImmunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 YearsWho this might be right forHerpes Zoster GlaxoSmithKline 410
Large-scale testing (Phase 3)Study completedNCT02979639What this trial is testingStudy to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of AgeWho this might be right forHerpes Zoster GlaxoSmithKline 404
Large-scale testing (Phase 3)Study completedNCT03120364What this trial is testingImmunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverWho this might be right forHerpes Zoster SK Chemicals Co., Ltd. 824
Post-approval studies (Phase 4)Study completedNCT01682109What this trial is testingPalatability Testing of a New Paediatric Formulation of ValacyclovirWho this might be right forVaricella Zoster Virus InfectionHerpes Simplex Virus Infection Radboud University Medical Center 41
Not applicableStudy completedNCT04774458What this trial is testingProspective Observation of the Fluoroscopy-guided Cervical Epidural Approach Using the Contralateral Oblique ViewWho this might be right forCervical Intervertebral Disc DiseaseCervical Spinal StenosisCervical Radicular Pain+2 more Asan Medical Center 439